1995
DOI: 10.1016/0272-6386(95)90657-6
|View full text |Cite
|
Sign up to set email alerts
|

Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
174
0

Year Published

2000
2000
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 266 publications
(179 citation statements)
references
References 16 publications
3
174
0
Order By: Relevance
“…Comorbidities were more common in Czech patients; only 16% had no comorbidities compared with 47% and 40% of the Swedish and English patients, respectively (P,0.001). Median BVAS was 12 (IQR, 9-12) in patients with renal-limited disease and 16 (IQR, [13][14][15][16][17][18][19] in patients with more than one organ system involved (P,0.001).…”
Section: Baseline Patient Characteristicsmentioning
confidence: 99%
“…Comorbidities were more common in Czech patients; only 16% had no comorbidities compared with 47% and 40% of the Swedish and English patients, respectively (P,0.001). Median BVAS was 12 (IQR, 9-12) in patients with renal-limited disease and 16 (IQR, [13][14][15][16][17][18][19] in patients with more than one organ system involved (P,0.001).…”
Section: Baseline Patient Characteristicsmentioning
confidence: 99%
“…On the basis of the number of comorbid conditions, a patient was classified according to the Davies' comorbidity index as having no, intermediate, or severe comorbidity (25,26).…”
Section: Data Collection Proceduresmentioning
confidence: 99%
“…Birtay T et al: Vascular Access Type Body Fat and MIAC in Hemodialysis infarction, angina, or ischemic changes on EKG), left ventricular dysfunction (defined as clinical evidence of pulmonary edema not due to errors in fluid balance, or history of congestive heart failure), peripheral vascular disease (includes distal aortic, lower extremity, and cerebrovascular disease), malignancy, diabetes, collagen vascular disease, and other significant pathology (e.g., chronic obstructive pulmonary disease) (25). This Score is designed for peritoneal dialysis patients and commonly used in Europe for adjusting co-morbidity.…”
Section: Türk Nefroloji Diyaliz Ve Transplantasyon Dergisi Turkish Nementioning
confidence: 99%